Hoffmann-la Roche Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOFFMANN-LA ROCHE, and what generic alternatives to HOFFMANN-LA ROCHE drugs are available?
HOFFMANN-LA ROCHE has two approved drugs.
There are five US patents protecting HOFFMANN-LA ROCHE drugs.
There are one hundred and nineteen patent family members on HOFFMANN-LA ROCHE drugs in thirty-nine countries and twenty-one supplementary protection certificates in sixteen countries.
Summary for Hoffmann-la Roche
International Patents: | 119 |
US Patents: | 5 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Hoffmann-la Roche: | See patent lawsuits for Hoffmann-la Roche |
Drugs and US Patents for Hoffmann-la Roche
Expired US Patents for Hoffmann-la Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche | INVIRASE | saquinavir mesylate | TABLET;ORAL | 021785-001 | Dec 17, 2004 | 5,196,438*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Hoffmann-la Roche Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hong Kong | 1165794 | ⤷ Try a Trial |
Australia | 2010259588 | ⤷ Try a Trial |
Poland | 2441753 | ⤷ Try a Trial |
Mexico | 2021012300 | ⤷ Try a Trial |
Russian Federation | 2015156881 | ⤷ Try a Trial |
Morocco | 33418 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hoffmann-la Roche Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0432695 | C970013 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
2441753 | 300876 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ALECTINIB DAN WEL EEN ZOUT OF SOLVAAT DAARVAN; REGISTRATION NO/DATE: EU/1/16/1169/001 20170220 |
2441753 | 2017026 | Norway | ⤷ Try a Trial | PRODUCT NAME: ALEKTINIB ELLER SALT ELLER SOLVAT; REG. NO/DATE: EU/1/16/1169 20170307 |
2441753 | SPC/GB17/036 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ALECTINIB (9-ETHYL-6,6-DIMETHYL-8-(4-MORPHOLIN-4-YL-PIPERIDIN-1-YL)-11-OXO-6,11-DIHYDRO-5H-BENZO(B)CARBAZOLE-3-CARBONITRILE) OR A SALT OR SOLVATE THEREOF; REGISTERED: UK EU/1/16/1169 (NI) 20170220; UK PLGB 00031/0843 20170220 |
0432695 | 96C0044 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
2441753 | 2017/026 | Ireland | ⤷ Try a Trial | PRODUCT NAME: ALECTINIB OR SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/16/1169/001 20170216 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.